Literature DB >> 22556199

Midterm results of surgical hip dislocation for the treatment of femoroacetabular impingement.

Florian D Naal1, Hermes H Miozzari, Michael Schär, Tobias Hesper, Hubert P Nötzli.   

Abstract

BACKGROUND: Surgical treatment of femoroacetabular impingement (FAI) includes both open and arthroscopic procedures. Encouraging results have been reported for the majority of patients after surgical hip dislocation; however, most of these reports were short term and included only small cohorts.
PURPOSE: To determine the results of surgical hip dislocation in a large cohort of FAI patients at a midterm follow-up. STUDY
DESIGN: Case series; Level of evidence, 4.
METHODS: A retrospective study including 185 consecutive patients (mean age, 30 years; 40% female) with 233 hips treated was conducted. We determined clinical outcomes in terms of range of motion and analyzed radiographs for several criteria including the alpha angle preoperatively and at 1 year postoperatively. At latest follow-up, on average 61 months postoperatively, patient satisfaction, the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), Hip Outcome Score, SF-12, and University of California, Los Angeles (UCLA) activity scale scores were determined. All revisions and conversions to total hip arthroplasty (THA) were recorded.
RESULTS: Both hip flexion and internal rotation improved from preoperatively to postoperatively. Alpha angles decreased from 65.1° ± 14.2° to 42.4° ± 4.9°. At 5 years, 82% of the patients were satisfied or very satisfied with the results of surgery, and 81% would undergo the same surgery again. There were 83% who rated their overall hip function as normal or nearly normal. Mean scores for the WOMAC pain, stiffness, and function subscales were 10.3 ± 15.8, 15.9 ± 17.4, and 9.6 ± 13.0 points; for Hip Outcome Score activities of daily living and sport subscales were 89.0 ± 13.1 and 75.6 ± 23.0 points; and for the SF-12 Physical Component Scale and Mental Component Scale were 47.4 ± 6.3 and 52.3 ± 7.4 points, respectively. The mean UCLA activity level was 7.7 ± 1.9. Conversion to THA was performed in 7 hips (3%). Seven hips (3%) underwent other major revisions, and 11 (4.7%) underwent minor revisions. Female patients had a significantly increased risk for conversion to THA (odds ratio, 13.3; 95% confidence interval [CI], 1.3-92.6) and major revision (odds ratio, 19.2; 95% CI, 2.4-152.9). The mean body mass index was significantly lower in those patients who underwent conversion to THA. The need for microfracture because of residual full-thickness cartilage defects after rim trimming was a significant (P = .04) predictor of subjective dissatisfaction.
CONCLUSION: This study demonstrates that surgical hip dislocation is a successful procedure for the treatment of FAI. A majority of patients were satisfied with the results of surgery at a midterm follow-up. Older and slim female patients were at an increased risk for a less successful outcome in terms of conversion to THA and revision surgery.

Entities:  

Mesh:

Year:  2012        PMID: 22556199     DOI: 10.1177/0363546512445884

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  29 in total

1.  No regeneration of the human acetabular labrum after excision to bone.

Authors:  Hermes H Miozzari; Marco Celia; John M Clark; Stefan Werlen; Florian D Naal; Hubert P Nötzli
Journal:  Clin Orthop Relat Res       Date:  2015-04       Impact factor: 4.176

2.  Eighty percent of patients with surgical hip dislocation for femoroacetabular impingement have a good clinical result without osteoarthritis progression at 10 years.

Authors:  Simon D Steppacher; Helen Anwander; Corinne A Zurmühle; Moritz Tannast; Klaus A Siebenrock
Journal:  Clin Orthop Relat Res       Date:  2015-04       Impact factor: 4.176

Review 3.  Factors Associated With the Failure of Surgical Treatment for Femoroacetabular Impingement: Review of the Literature.

Authors:  Ehsan Saadat; Scott D Martin; Thomas S Thornhill; Sarah A Brownlee; Elena Losina; Jeffrey N Katz
Journal:  Am J Sports Med       Date:  2013-08-30       Impact factor: 6.202

4.  Hips With Protrusio Acetabuli Are at Increased Risk for Failure After Femoroacetabular Impingement Surgery: A 10-year Followup.

Authors:  Markus S Hanke; Simon D Steppacher; Corinne A Zurmühle; Klaus A Siebenrock; Moritz Tannast
Journal:  Clin Orthop Relat Res       Date:  2016-10       Impact factor: 4.176

5.  Periacetabular Osteotomy Provides Higher Survivorship Than Rim Trimming for Acetabular Retroversion.

Authors:  Corinne A Zurmühle; Helen Anwander; Christoph E Albers; Markus S Hanke; Simon D Steppacher; Klaus A Siebenrock; Moritz Tannast
Journal:  Clin Orthop Relat Res       Date:  2016-12-05       Impact factor: 4.176

6.  Surgical hip dislocation for treatment of femoroacetabular impingement: factors predicting 5-year survivorship.

Authors:  Simon D Steppacher; Carmen Huemmer; Joseph M Schwab; Moritz Tannast; Klaus A Siebenrock
Journal:  Clin Orthop Relat Res       Date:  2013-09-08       Impact factor: 4.176

Review 7.  Radiographic outcomes following femoroacetabular impingement correction with open surgical management: a systematic review.

Authors:  R Kyle Martin; Ivan Dzaja; Jeffrey Kay; Muzammil Memon; Andrew Duong; Nicole Simunovic; Olufemi R Ayeni
Journal:  Curr Rev Musculoskelet Med       Date:  2016-12

8.  What MRI Findings Predict Failure 10 Years After Surgery for Femoroacetabular Impingement?

Authors:  Markus S Hanke; Simon D Steppacher; Helen Anwander; Stefan Werlen; Klaus A Siebenrock; Moritz Tannast
Journal:  Clin Orthop Relat Res       Date:  2017-04       Impact factor: 4.176

9.  [Surgical hip dislocation : Current status in the treatment of femoral acetabular impingement].

Authors:  F Sitterlee; S Kirschbaum; C Perka; M Müller
Journal:  Orthopade       Date:  2017-09       Impact factor: 1.087

10.  Validation of a self-reported Beighton score to assess hypermobility in patients with femoroacetabular impingement.

Authors:  Florian D Naal; Gabriel Hatzung; Aileen Müller; Franco Impellizzeri; Michael Leunig
Journal:  Int Orthop       Date:  2014-07-05       Impact factor: 3.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.